z-logo
open-access-imgOpen Access
MP65-16 NOVEL BIOMARKER SIGNATURE FOR PREDICTING PATHOLOGIC RESPONSE OF UROTHELIAL CARCINOMA OF THE BLADDER TO CISPLATIN-BASED NEOADJUVANT CHEMOTHERAPY
Author(s) -
Patrick J. Hensley,
Matthew S. Purdom,
Natasha Kyprianou,
Chi Wang,
Andrew James
Publication year - 2018
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2018.02.2082
Subject(s) - medicine , cystectomy , bladder cancer , cisplatin , tissue microarray , oncology , biomarker , chemotherapy , neoadjuvant therapy , stage (stratigraphy) , cancer , urology , pathology , breast cancer , biochemistry , chemistry , biology , paleontology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom